The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats
Open accessAbstract
Both insulin resistance and hyperinsulinemia have been reported to be independent risk factors for cardiovascular diseases. However, little is known regarding insulin signaling in the vascular tissues in insulin-resistant states. In this report, insulin signaling on the phosphatidylinositol 3-kinase (PI 3-kinase) and mitogen-activated protein (MAP) kinase pathways were compared in vascular tissues of lean and obese Zucker (fa/fa) rats in both ex vivo and in vivo studies. Ex vivo, insulin-stimulated tyrosine phosphorylation of insulin receptor beta subunits (IRbeta) in the aorta and microvessels of obese rats was significantly decreased compared with lean rats, although the protein levels of IRbeta in the 2 groups were not different. Insulin-induced tyrosine phosphorylation of insulin receptor substrates 1 and 2 (IRS-1 and IRS-2) and their protein levels were decreased in the aorta of obese rats compared with lean rats. The association of p85 subunit to the IRS proteins and the IRS-associated PI 3-kinase activities stimulated by insulin in the aorta of obese rats were significantly decreased compared with the lean rats. In addition, insulin-stimulated serine phosphorylation of Akt, a downstream kinase of PI 3-kinase pathway, was also reduced significantly in isolated microvessels from obese rats compared with the lean rats. In euglycemic clamp studies, insulin infusion greatly increased tyrosine phosphorylation of IRbeta- and IRS-2-associated PI 3-kinase activity in the aorta of lean rats, but only slight increases were observed in obese rats. In contrast, insulin stimulated tyrosine phosphorylation of MAP kinase (ERK-1/2) equally in isolated microvessels of lean and obese rats, although basal tyrosine phosphorylation of ERK-1/2 was higher in the obese rats. To our knowledge, these data provided the first direct measurements of insulin signaling in the vascular tissues, and documented a selective resistance to PI 3-kinase (but not to MAP kinase pathway) in the vascular tissues of obese Zucker rats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [60]
Experimental — accuracy not yet measuredIn the citing paper
“Vascular insulin resistance leads to downregulation of IRS-1 and 2 and decreased phosphorylation of Akt and eNOS, whereas the ET-1 pathway remains unaffected.”
From The Vasculature in Prediabetes (2018) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 2×
“However, physiological studies have documented that endothelial functions as measured by insulin-induced vasodilatation are reduced in insulin-resistant and diabetic patients (12), suggesting that vascular cells are also resistant to insulin for some of its physiological actions.”
BackgroundStructure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Self-citationMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. S., & Baron, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,216
Insulin Stimulates the Phosphorylation of the 95,000-Dalton Subunit of Its Own Receptor
Kasuga, M., Karlsson, F. A., & Kahn, C. R. (1982) · Science · doi:10.1126/science.7031900 · Cited by 1,132
The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.
DeFronzo, R. A., Cooke, C. R., Andres, R., Faloona, G. R., & Davis, P. J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107996 · Cited by 1,104
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Research works printed but not linked: 5
- Kuboki, 1998, Diabetes, 47(Suppl. 1), A24
- Cheatham, 1994, Mol Cell Biol, 14, 4902, 10.1128/MCB.14.7.4902 · DOI
- Myers, 1994, Mol Cell Biol, 14, 357
- Bray, 1977, Fed Proc, 36, 148
- Moncada, 1991, Pharmacol Rev, 43, 109
Cited by
Sorted by citations
Items 301–400 of 604
Hodroj, W., Legedz, L., Foudi, N., Cerutti, C., Bourdillon, M. C., Feugier, P., Beylot, M., Randon, J., & Bricca, G. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000254814.63768.3b · Cited by 34
Insulin resistance in penile arteries from a rat model of metabolic syndrome
Contreras, C., Sánchez, A., Martínez, M. P., Raposo, R., Climent, B., García‐Sacristán, A., Benedito, S., & Prieto, D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00825.x · Cited by 34
Madonna, R., Massaro, M., Pandolfi, A., Consoli, A., & Caterina, R. D. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000312 · Cited by 34
Insulin exhibits short-term anti-inflammatory but long-term proinflammatory effects in vitro
Iwasaki, Y., Nishiyama, M., Taguchi, T., Asai, M., Yoshida, M., Kambayashi, M., Terada, Y., & Hashimoto, K. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.030 · Cited by 34
Serné, E. H., de Jongh, R. T., Eringa, E. C., IJzerman, R. G., de Boer, M. P., & Stehouwer, C. D. A. (2006) · Essays in Biochemistry · doi:10.1042/bse0420163 · Cited by 34
Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
Goetze, S., Kim, S., Xi, X., Graf, K., Yang, D., Fleck, E., Meehan, W. P., Hsueh, W. A., & Law, R. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200005000-00011 · Cited by 37
Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy
Dong, W., Chao, M., Lu, Q., Chai, W., Zhang, W., Chen, X., Liang, E., Wang, L., Tian, H., Chen, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6384 · Cited by 33
Ugwoke, C. K., Cvetko, E., & Umek, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020847 · Cited by 38
Igarashi, M., Hirata, A., Yamaguchi, H., Tsuchiya, H., Ohnuma, H., Tominaga, M., Daimon, M., & Kato, T. (2001) · Hypertension · doi:10.1161/hy1101.095537 · Cited by 33
Self-citationInsulin resistance in vascular endothelial cells promotes intestinal tumour formation
Wang, X., Häring, M.-F., Rathjen, T., Lockhart, S. M., Sørensen, D., Ussar, S., Rasmussen, L. M., Bertagnolli, M. M., Kahn, C. R., & Rask‐Madsen, C. (2017) · Oncogene · doi:10.1038/onc.2017.107 · Cited by 32
Lightell, D., Moss, S. C., & Woods, T. C. (2010) · Endocrinology · doi:10.1210/en.2010-0722 · Cited by 32
Mikus, C. R., Roseguini, B. T., Uptergrove, G. M., Morris, E. M., Rector, R. S., Libla, J. L., Oberlin, D. J., Borengasser, S. J., Taylor, A. M., Ibdah, J. A., et al. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2012.00210.x · Cited by 31
Kokaji, T., Hatano, A., Ito, Y., Yugi, K., Eto, M., Morita, K., Ohno, S., Fujii, M., Hironaka, K., Egami, R., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz1236 · Cited by 29
Blumensatt, M., Wronkowitz, N., Wiza, C., Cramer, A., Mueller, H., Rabelink, M. J. W. E., Hoeben, R. C., Eckel, J., Sell, H., & Ouwens, D. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.001 · Cited by 31
Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome
Bełtowski, J., Wójcicka, G., Jamróz-Wiśniewska, A., & Marciniak, A. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.08.002 · Cited by 30
Pathophysiology of the proatherothrombotic state in the metabolic syndrome
Navarro, H. G. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s57 · Cited by 32
Kobayashi, T., Taguchi, K., Nemoto, S., Nogami, T., Matsumoto, T., & Kamata, K. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00536.2009 · Cited by 30
Even, S., Dulak-Lis, M. G., Touyz, R. M., & Cat, A. N. D. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0013 · Cited by 30
Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice
Tentolouris, A., Eleftheriadou, I., Tzeravini, E., Tsilingiris, D., Paschou, S. Α., Siasos, G., & Tentolouris, N. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190119154152 · Cited by 31
Sugita, M., Sugita, H., & Kaneki, M. (2004) · Hypertension · doi:10.1161/01.hyp.0000140778.53811.20 · Cited by 30
Endothelial Function in Youth: A Biomarker Modulated by Adiposity-Related Insulin Resistance
Tomsa, A., Bartz, S. K., Krishnamurthy, R., Krishnamurthy, R., & Bacha, F. F. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.07.025 · Cited by 29
Qi, W., Li, Q., Liew, C. W., Rask‐Madsen, C., Lockhart, S. M., Rasmussen, L. M., Xia, Y., Wang, X., Khamaisi, M., Croce, K., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4159-1 · Cited by 30
Self-citationExercise training increases ERK2 activity in skeletal muscle of obese Zucker rats
Osman, A. A., Hancock, J., Hunt, D. G., Ivy, J. L., & Mandarino, L. J. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.2.454 · Cited by 30
YAMAGUCHI, K., Higashiura, K., Ura, N., MURAKAMI, H., Hyakukoku, M., Furuhashi, M., & Shimamoto, K. (2003) · Hypertension Research · doi:10.1291/hypres.26.389 · Cited by 30
Insulin receptors in vascular smooth muscle cells regulate plaque stability of atherosclerosis
Li, Q., Fu, J., Park, K., Shah, H., Li, Q., Wu, I., & King, G. L. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae193 · Cited by 30
Self-citationGender Difference in Type 1 Diabetes: An Underevaluated Dimension of the Disease
Tatti, P., & Pavandeep, S. (2022) · Diabetology · doi:10.3390/diabetology3020027 · Cited by 29
New insights into mechanisms of endothelial insulin resistance in type 2 diabetes
Padilla, J., Manrique‐Acevedo, C., & Martinez‐Lemus, L. A. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00537.2022 · Cited by 29
Fakhrzadeh, H., Alatab, S., Sharifi, F., Mirarefein, M., Badamchizadeh, Z., Ghaderpanahi, M., Taheri, A. P. H., & Larijani, B. A. (2012) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2011.01829.x · Cited by 28
Nishimura, M., Tsukamoto, K., Tamaki, N., Kikuchi, K., Iwamoto, N., & Ono, T. (2010) · Kidney International · doi:10.1038/ki.2010.392 · Cited by 29
Enhanced insulin signaling via Shc in human breast cancer
Finlayson, C. A., Chappell, J., Leitner, J. W., Goalstone, M. L., Garrity, M., Nawaz, S., Ciaraldi, T. P., & Draznin, B. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00311-1 · Cited by 29
Dissociation between metabolic and vascular insulin resistance in aging
Schulman, I. H., Zhou, M.-S., Jaimes, E. A., & Raij, L. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00138.2007 · Cited by 28
Glucocorticoids and Insulin Sensitivity: Dissociation of Insulin’s Metabolic and Vascular Actions
Perry, C. G., Spiers, A., Cleland, S. J., Lowe, G. D. O., Petrie, J. R., & Connell, J. M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021605 · Cited by 29
Effects of Acquired Obesity on Endothelial Function in Monozygotic Twins
Pietiläinen, K. H., Bergholm, R., Rissanen, A., Kaprio, J. A., Häkkinen, A., Sattar, N. A., & Yki‐Järvinen, H. (2006) · Obesity · doi:10.1038/oby.2006.96 · Cited by 28
Rroji, M., Spahia, N., Figurek, A., & Spasovski, G. B. (2025) · Biomedicines · doi:10.3390/biomedicines13030728 · Cited by 31
Harmancey, R., Haight, D. L., Watts, K. A., & Taegtmeyer, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.673988 · Cited by 28
Metformin improves skeletal muscle microvascular insulin resistance in metabolic syndrome
Jahn, L. A., Hartline, L. M., Liu, Z., & Barrett, E. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00287.2021 · Cited by 28
Adiponectin resistance and vascular dysfunction in the hyperlipidemic state
Li, R., Lau, W. B., & Liang, X. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.95 · Cited by 28
Complications of Diabetes Mellitus
Brownlee, M., Aiello, L. P., Cooper, M. E., Vinik, A. I., Plutzky, J., & Boulton, A. J. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00033-2 · Cited by 29
Shinozaki, K., Ayajiki, K., Kashiwagi, A., Masada, M., & Okamura, T. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fmj04006x4 · Cited by 28
Comprehensive treatment of diabetic endothelial dysfunction based on pathophysiological mechanism
Liu, Z., Lu, J., Sha, W., & Lei, T. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1509884 · Cited by 34
Li, Y., Huang, C., Fu, W., Zhang, H., Lao, Y., Zhou, H., Tan, H., & Xu, H. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112645 · Cited by 27
Insulin Resistance and Atherosclerosis
Raghavan, V. A. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.014 · Cited by 27
Contreras, C., Sánchez, A., García‐Sacristán, A., Martínez, M. C., Andriantsitohaina, R., & Prieto, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.036 · Cited by 27
Obesity, Insulin Resistance and Hepatic Perfusion
Brock, R. W., & Dorman, R. B. (2007) · Microcirculation · doi:10.1080/10739680701282986 · Cited by 27
Lin, Y., Juan, C., Kwok, C., Hsu, Y.-P., Shih, K., Chen, C., & Ho, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.017 · Cited by 26
Self-citationElgebaly, M. M., Kelly, A. I., Harris, A. K., Elewa, H. F., Portik‐Dobos, V., Ketsawatsomkron, P., Marrero, M. B., & Ergul, A. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-034 · Cited by 26
Insulin resistance in Type 2 diabetes and obesity: implications for endothelial function
Aziz, A., & Wheatcroft, S. B. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.20 · Cited by 25
Pioglitazone and mechanisms of CV protection
Erdmann, E., & Wilcox, R. G. (2009) · QJM · doi:10.1093/qjmed/hcp168 · Cited by 25
Bedinger, D., Goldfine, I. D., Corbin, J., Roell, M. K., & Adams, S. H. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221309 · Cited by 25
Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis
Taguchi, K., Hida, M., Hasegawa, M., Narimatsu, H., Matsumoto, T., & Kobayashi, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-08998-5 · Cited by 25
Why does diabetes mellitus increase the risk of cardiovascular disease?
Shahab, A. (2006) · PubMed · Cited by 25
Nishimura, M., Murase, M., Hashimoto, T., Kobayashi, H., Yamazaki, S., Imai, R., Okino, K., Fujita, H., Inoue, N., Takahashi, H., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000100 · Cited by 25
Insulin Resistance in Type 2 Diabetes
Yki‐Järvinen, H. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch11 · Cited by 27
Vikram, A., Jena, G., & Ramarao, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00994.x · Cited by 24
Wang, X., Lockhart, S. M., Rathjen, T., Albadawi, H., Sørensen, D., O'Neill, B. T., Dwivedi, N., Preil, S. R., Beck, H. C., Dunwoodie, S. L., et al. (2016) · Diabetes · doi:10.2337/db16-0001 · Cited by 24
Hyakukoku, M., Higashiura, K., Ura, N., MURAKAMI, H., YAMAGUCHI, K., Ling, W. A. N. G., Furuhashi, M., Togashi, N., & Shimamoto, K. (2003) · Hypertension Research · doi:10.1291/hypres.26.169 · Cited by 23
Why Does Obesity Increase the Risk for Cardiovascular Disease?
Boden, G. H., & Salehi, S. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319320003 · Cited by 23
Boden, G. H., Cheung, P., Kresge, K. M., Homko, C. J., Powers, B. D., & Ferrer, L. M. (2014) · Diabetes · doi:10.2337/db14-0055 · Cited by 23
Cotero, V. E., Zhang, B. B., & Routh, V. H. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01938.x · Cited by 23
Costa, M. M., Violato, N. M., Taboga, S. R., Góes, R. M., & Bosqueiro, J. R. (2012) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2012.00817.x · Cited by 23
Eggleston, E., Jahn, L. A., & Barrett, E. J. (2012) · Diabetes Care · doi:10.2337/dc11-2399 · Cited by 23
Manrique, C. M., & Sowers, J. R. (2014) · Cardiorenal Medicine · doi:10.1159/000368423 · Cited by 23
Noh, H., Yu, M. R., Kim, H. J., Jang, E. J., Hwang, E. S., Jeon, J. S., Kwon, S. H., & Han, D. C. (2014) · Stem Cells · doi:10.1002/stem.1738 · Cited by 22
Olver, T. D., Grunewald, Z. I., Ghiarone, T., Restaino, R. M., Sales, A. R. K., Park, L. K., Thorne, P. K., Ganga, R., Emter, C. A., Lemon, P. W. R., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00464.2019 · Cited by 21
Akther, F., Razan, M. R., Shaligram, S. S., Graham, J. L., Stanhope, K. L., Allen, K. N., Vázquez‐Medina, J. P., Havel, P. J., & Rahimian, R. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.616317 · Cited by 23
Zhou, Q. G., Fu, X., Xu, G., Cao, W., Liu, H. F., Nie, J., Liang, M., & Hou, F. F. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00407.2012 · Cited by 21
Relationship Between Metabolic Syndrome and Cognitive Abilities in U.S. Adolescents
Rubens, M., Ramamoorthy, V., Saxena, A., George, F., Shehadeh, N., Attonito, J. M., McCoy, H. V., & Beck‐Sagué, C. M. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0015 · Cited by 21
Anti-Atherogenic Effect of Insulin in vivo
Kim, T., Chan, K. K., Dhaliwall, J. K., Huynh, N., Suen, R. S., Uchino, H., Naigamwalla, D. Z., Bendeck, M. P., & Giacca, A. (2005) · Journal of Vascular Research · doi:10.1159/000088099 · Cited by 21
Effects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors
Boden, G. H., Song, W., Kresge, K. M., Mozzoli, M. A., & Cheung, P. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90370.2008 · Cited by 21
Insulin Signaling in Arteries Prevents Smooth Muscle Apoptosis
Nakazawa, T., Chiba, T., Kaneko, E., Yui, K., Yoshida, M., & Shimokado, K. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000158307.66945.b4 · Cited by 21
Shittu, S.-T. T., Lasisi, T. J., Shittu, S.-S., Adeyemi, A. A., Adeoye, T., & Alada, A. R. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00850-y · Cited by 20
Lu, H., Huang, D., Kang, Y., Li, C., Chang, S., Dai, Y., Sun, A., Zou, Y., Qian, J., & Ge, J. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.03.005 · Cited by 20
Erkens, R., Totzeck, M., Brum, A., Duse, D. A., Bøtker, H. E., Rassaf, T., & Kelm, M. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.040 · Cited by 19
Ji, Z., Luo, J., Su, T., Chen, C., & Su, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s288482 · Cited by 20
Ihlemann, N., Stokholm, K. H., & ESKILDSEN, P. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00715.x · Cited by 20
Possible Involvement of Akt Activity in Endothelial Dysfunction in Type 2 Diabetic Mice
Takenouchi, Y., Kobayashi, T., Matsumoto, T., & Kamata, K. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0071684 · Cited by 20
Turaihi, A. H., Bakker, W., van Hinsbergh, V. W. M., Serné, E. H., Smulders, Y. M., Niessen, H. W. M., & Eringa, E. C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00245 · Cited by 18
Gómez‐Hernández, A., Heras, N. D. L., López‐Pastor, A. R., García-Gómez, G., Infante‐Menéndez, J., González‐López, P., González‐Illanes, T., Lahera, V., Benito, M., & Escribano, Ó. (2021) · Cells · doi:10.3390/cells10082035 · Cited by 19
The vascular endothelium in diabetes and its potential as a therapeutic target
Liu, Z. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9238-8 · Cited by 19
Mechanisms of Vascular Insulin Resistance
Fulton, D. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.198028 · Cited by 19
Zhou, C., Huang, Z., Lin, H., Wang, J., Wang, Y., & Yu, W. (2021) · Aquaculture Reports · doi:10.1016/j.aqrep.2021.100626 · Cited by 18
Insulin stimulates arterial neointima formation in normal rats after balloon injury
Foster, E. A., Zhang, S., & Kahn, A. M. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00513.x · Cited by 18
Stimulatory Effect of Leptin on Nitric Oxide Production Is Impaired in Dietary‐Induced Obesity
Bełtowski, J., Wójcicka, G., & Jamroz, A. (2003) · Obesity Research · doi:10.1038/oby.2003.209 · Cited by 18
Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans
Lteif, A. A., Fulford, A. D., Considine, R. V., Gelfand, I. M., Baron, A., & Mather, K. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90549.2008 · Cited by 18
Pandolfi, A., Solini, A., Pellegrini, G., Mincione, G., Silvestre, S. D., Chiozzi, P., Giardinelli, A., Marcantonio, M. C. D., Piccirelli, A., Capani, F., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000185831.13559.a2 · Cited by 18
Huisamen, B., Donthi, R. V., & Lochner, A. (2001) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1013358011019 · Cited by 18
Wada, N., Takaki, A., Ikeda, F., Yasunaka, T., Onji, M., Nouso, K., Nakatsuka, A., Wada, J., KOIKE, K. A., Miyahara, K., et al. (2016) · Hepatology International · doi:10.1007/s12072-016-9773-y · Cited by 17
Mughal, R. S., Bridge, K., Buza, I., Slaaby, R., Worm, J., Povlsen, G. K., Hvid, H., Schiødt, M., Cubbon, R. M., Yuldasheva, N. Y., et al. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118802550 · Cited by 17
Recent Advances in the Treatment of Erectile Dysfunction in Patients with Diabetes Mellitus
Koppiker, N., Boolell, M., & Price, D. E. (2003) · Endocrine Practice · doi:10.4158/ep.9.1.52 · Cited by 16
Li, Q., Zhao, C., Liu, M., Li, M., Zhang, Y., & Yue, C. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02556-z · Cited by 16
Tan, Z., Zhou, D., Tang, Y., & Huo, G. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1537774 · Cited by 17
Complications of Diabetes Mellitus
Brownlee, M., Aiello, L. P., Cooper, M. E., Vinik, A. I., Nesto, R. W., & Boulton, A. J. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00033-x · Cited by 16
Roussel, R., Natali, A., Balkau, B., Højlund, K., Sánchez, G., Nolan, J. J., Mari, A., Kozàkovà, M., & Bonnet, F. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000842 · Cited by 15
Long, Y., Xia, J., Chen, S.-W., Gao, C., Liang, G.-N., He, X., Wu, J., Jiang, C., Liu, X., Huang, W., et al. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19666 · Cited by 15
Chen, X., Yao, F., Song, J. T., Fu, B., Sun, G., Song, X., Fu, C., Jiang, R., & Sun, L. (2020) · Journal of Food Science · doi:10.1111/1750-3841.15071 · Cited by 15
Yousif, M. H. M., Benter, I. F., Hares, N., Canatan, H., & Akhtar, S. (2005) · Cell Biochemistry and Function · doi:10.1002/cbf.1278 · Cited by 15
WANG, C., Sharma, G. D., & Draznin, B. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.10.014 · Cited by 15
Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A., Mandarino, L. J., & Ferrannini, E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0310 · Cited by 15
Evidence Stacks Up That Endothelial Insulin Resistance Is a Culprit in Atherosclerosis
Kanter, J. E., & Bornfeldt, K. (2013) · Circulation Research · doi:10.1161/circresaha.113.301998 · Cited by 15
Jahn, L. A., Hartline, L. M., Nguyen, T. T. D., Aylor, K. W., Horton, W. B., Liu, Z., & Barrett, E. J. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00267.2023 · Cited by 16
Metadata
- Authors
- Jiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- King, George L.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-08-15
- Volume
- 104
- Issue
- 4
- Pages
- 447-457
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408521
- OpenAlex
- W2051269098
- Cited by
- 604
- References
- 56
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 10 · 2023: 15 · 2022: 15 · 2021: 19 · 2020: 13 · 2019: 13 · 2018: 10 · 2017: 24 · 2016: 28 · 2015: 24 · 2014: 23 · 2013: 27 · 2012: 35
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Joslin Diabetes Center
- National Institutes of Health (DK 36836)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-53105, DK36836, R01DK053105, P30DK036836)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin resistance, MAPK signaling, ERK1/2, insulin receptor beta, IRS-1, insulin receptor substrate 2, p85 regulatory subunit, aorta, microvessels, obesity, Zucker rats, hyperinsulinemia, cardiovascular risk
- MeSH terms
- Animals, Aorta, Insulin, Insulin Resistance, Liver, Male, Microcirculation, Obesity, Phosphoproteins, Phosphorylation, Rats, Zucker, Receptor, Insulin, Recombinant Proteins, Tyrosine, Signal Transduction, Calcium-Calmodulin-Dependent Protein Kinases, Phosphatidylinositol 3-Kinases, Intracellular Signaling Peptides and Proteins, Rats, Insulin Receptor Substrate Proteins, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review